Insider · CIK 0001769749
Tess Burleson
Files at DCOY (Salarius Pharmaceuticals, Inc.). First filing -, latest -.
Tess Burleson files SEC Form 4 as director at DCOY (Salarius Pharmaceuticals, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Tess Burleson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | DCOY Salarius Pharmaceuticals, Inc. | AGrant or award Common Stock | +2,000 | $0.00 | $0 | 2,002 | 41 d ago |
Questions about Tess Burleson
Answered from the filings on this page, as of the latest one.
Is Tess Burleson buying or selling?
Tess Burleson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Tess Burleson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tess Burleson has 0.
Where does Tess Burleson file Form 4?
Tess Burleson has filed Form 4 at DCOY (Salarius Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.